CSL signs agreement with Australian Government for UQ vaccine supply
Global biotech company CSL Limited will supply the Australian Government with 51 million
doses of The Un
iversity of Queensland’s COVID-19 vaccine candidate if it proves successful, under a heads of agreement announced today.
CSL expects the first tranche of doses to be available by mid-2021, with additional doses following in late 2021 and early 2022, if late stage clinical trials are successful.